From: The effects of the COVID-19 pandemic on patients with lysosomal storage disorders in Israel
Symptom onset | Association with mood deterioration (N = 48) | |
---|---|---|
Pv | OR (CI) | |
Aggressiveness (N = 48) |  < 0.001 | 76 (6.7–855.9) |
Cognitive function decline (N = 48) |  < 0.001 | 37 (5.1–269.7) |
Motoric function deterioration (N = 46) | 0.001 | 12.8 (2.4–68.4) |